Innate Pharma S.A. (OTCMKTS:IPHYF – Get Free Report) was the recipient of a significant drop in short interest in the month of August. As of August 31st, there was short interest totalling 4,900 shares, a drop of 21.0% from the August 15th total of 6,200 shares. Based on an average daily volume of 200 shares, the days-to-cover ratio is currently 24.5 days.
Innate Pharma Price Performance
OTCMKTS:IPHYF remained flat at $2.30 during midday trading on Tuesday. The business’s 50 day moving average price is $2.10 and its 200-day moving average price is $2.33. Innate Pharma has a 1-year low of $1.93 and a 1-year high of $3.00.
About Innate Pharma
See Also
- Five stocks we like better than Innate Pharma
- Profitably Trade Stocks at 52-Week Highs
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- Investing in the High PE Growth Stocks
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- What is a Bond Market Holiday? How to Invest and Trade
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Receive News & Ratings for Innate Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Innate Pharma and related companies with MarketBeat.com's FREE daily email newsletter.